**Core Concept**
Sjögren's syndrome is a systemic autoimmune disease characterized by lymphocytic infiltration and destruction of exocrine glands, particularly the salivary and lacrimal glands. The development of lymphoma in Sjögren's syndrome is associated with specific clinical manifestations that reflect immune dysregulation and lymphoproliferation.

**Why the Correct Answer is Right**
High C4 complement levels are typically seen in conditions characterized by activation of the classical pathway of complement, such as rheumatoid arthritis or lupus. In contrast, Sjögren's syndrome is more commonly associated with low complement levels, particularly C4, due to activation of the alternative pathway. The development of lymphoma in Sjögren's syndrome is a distinct clinical scenario that often presents with different immunological features. High C4 complement levels are not a typical manifestation of lymphoma development in Sjögren's syndrome.

**Why Each Wrong Option is Incorrect**
**Option B:** Leucopenia can occur in Sjögren's syndrome due to lymphocytic infiltration of the bone marrow, which can lead to a decrease in white blood cell count. Leucopenia is a plausible manifestation of lymphoma development in Sjögren's syndrome.

**Option C:** Purpura can be a manifestation of lymphoma development in Sjögren's syndrome, particularly if the lymphoma involves the skin or leads to immune complex-mediated vasculitis.

**Option D:** Cryoglobulinemia is a well-known complication of Sjögren's syndrome, particularly in the context of lymphoma development. Cryoglobulins are abnormal proteins that precipitate in cold temperatures and can cause vasculitis, glomerulonephritis, and other manifestations.

**Clinical Pearl / High-Yield Fact**
When evaluating a patient with Sjögren's syndrome for lymphoma development, it is essential to consider the presence of low complement levels, particularly C4, and to investigate for other manifestations such as leucopenia, purpura, and cryoglobulinemia.

**✓ Correct Answer: A. High C4 Complement Levels**